News
Good News | Wanbangde Pharmaceutical's Bedano® Phloroglucinol Injection Selected as a "2024 Zhejiang Province Outstanding Industrial Product"!
Date:
29 Nov,2024
To create a "golden brand" for Zhejiang Province's outstanding industrial products, the Zhejiang Provincial Industrial Economy Federation, together with 64 provincial-level industry associations and city-level "Three Associations" across the province, has launched the "2024 Zhejiang Provincial Excellent Industrial Products" selection and promotion campaign.
After undergoing rigorous and meticulous procedures—including preliminary selection, expert review, public announcement, and the final decision-making process—Wanbangde Pharmaceutical Group Co., Ltd. has produced "Berdano® Phloroglucinol Injection" Standing out from thousands of products that participated in the review, Successfully selected as a "2024 Zhejiang Province Outstanding Industrial Product"! Meanwhile, the product has been licensed to use the "Zhejiang Province Excellent Industrial Product Logo," making it a premium industrial ambassador for Zhejiang.
The "Bedano® Phloroglucinol Injection," recently selected, is the first product nationwide to pass the consistency evaluation. It stands out as the only purely smooth-muscle spasmolytic and analgesic drug that falls outside both the atropine and papaverine categories. This achievement also marks a key milestone under Wanbangde Pharmaceutical Group’s dual development strategy of "API + Formulation," positioning it as one of the company’s flagship products. Administered via intramuscular or intravenous injection, the product is indicated for acute spastic pain caused by digestive system and biliary tract dysfunction, as well as acute spasms in the urethra, bladder, and renal colic. It is also effective for gynecological spastic pain conditions.
Being selected for the "Zhejiang Province Outstanding Industrial Products" list will further enhance the product's brand visibility and added value, strengthening its competitiveness and positively impacting its market promotion efforts. Moving forward, Wanbangde Pharmaceutical will continue to deepen its focus on the pharmaceutical and greater health sectors, closely aligning with market demands and consistently stepping up its innovation and R&D initiatives. By leveraging new, high-quality productivity, we’ll drive both the quantity and quality of our products, enabling us to strengthen and optimize our position in the competitive market—and ultimately paving the way for sustainable, high-quality growth!
Related Recommendations